GSK plc Announces Share Buyback Transaction on 23 October 2025

GSK plc, acting through BNP Paribas SA, purchased 366,000 of its ordinary shares on 23 October 2025 as part of its existing buyback program. The shares were bought at prices ranging from 1,640.00p to 1,657.50p, with a volume-weighted average price of 1,648.10p. The purchased shares will be held as Treasury shares. Following this transaction, GSK plc holds 253,192,344 ordinary shares in treasury and has 4,062,224,575 ordinary shares in issue, excluding Treasury shares. The total number of voting rights in the company is 4,062,224,575, with 6.23% of voting rights attributable to the Treasury shares.